• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Survival in bladder and renal cell cancers is familial.膀胱癌和肾细胞癌的生存率具有家族性。
J Am Soc Nephrol. 2008 May;19(5):985-91. doi: 10.1681/ASN.2007070818. Epub 2008 Feb 6.
2
Familial papillary renal cell tumors and subsequent cancers: a nationwide epidemiological study from Sweden.家族性乳头状肾细胞肿瘤及后续癌症:一项来自瑞典的全国性流行病学研究。
J Urol. 2003 Apr;169(4):1271-5. doi: 10.1097/01.ju.0000052373.36963.12.
3
Familial renal cell carcinoma from the Swedish Family-Cancer Database.从瑞典家族癌症数据库中发现的家族性肾细胞癌。
Eur Urol. 2011 Nov;60(5):987-93. doi: 10.1016/j.eururo.2011.05.031. Epub 2011 May 25.
4
Modification of cancer risks in offspring by sibling and parental cancers from 2,112,616 nuclear families.来自2,112,616个核心家庭的兄弟姐妹及父母患癌情况对后代患癌风险的影响
Int J Cancer. 2001 Apr 1;92(1):144-50.
5
Familial bladder cancer in the National Swedish Family Cancer Database.瑞典国家家庭癌症数据库中的家族性膀胱癌
J Urol. 2001 Dec;166(6):2129-33.
6
Parental lung cancer as predictor of cancer risks in offspring: clues about multiple routes of harmful influence?父母患肺癌作为子代癌症风险的预测因素:关于多种有害影响途径的线索?
Int J Cancer. 2006 Feb 1;118(3):744-8. doi: 10.1002/ijc.21387.
7
Familial risk of early and late onset cancer: nationwide prospective cohort study.家族癌症发病风险:全国前瞻性队列研究。
BMJ. 2012 Dec 20;345:e8076. doi: 10.1136/bmj.e8076.
8
Incidence and familial risk of pleural mesothelioma in Sweden: a national cohort study.瑞典胸膜间皮瘤的发病率和家族风险:一项全国性队列研究。
Eur Respir J. 2016 Sep;48(3):873-9. doi: 10.1183/13993003.00091-2016. Epub 2016 May 12.
9
Concordant and discordant familial cancer: Familial risks, proportions and population impact.一致性和不一致性家族性癌症:家族风险、比例及对人群的影响。
Int J Cancer. 2017 Apr 1;140(7):1510-1516. doi: 10.1002/ijc.30583. Epub 2017 Jan 20.
10
Zinc transporter genes and urological cancers: integrated analysis suggests a role for ZIP11 in bladder cancer.锌转运体基因与泌尿系统癌症:综合分析表明ZIP11在膀胱癌中发挥作用。
Tumour Biol. 2015 Sep;36(10):7431-7. doi: 10.1007/s13277-015-3459-2. Epub 2015 Apr 23.

引用本文的文献

1
Genetic insights into the morass of metastatic heterogeneity.遗传视角下转移性异质性的困境
Nat Rev Cancer. 2018 Apr;18(4):211-223. doi: 10.1038/nrc.2017.126. Epub 2018 Feb 9.
2
The role of individual inheritance in tumor progression and metastasis.个体遗传在肿瘤进展和转移中的作用。
J Mol Med (Berl). 2015 Jul;93(7):719-25. doi: 10.1007/s00109-015-1299-6. Epub 2015 Jun 10.
3
The prognostic value of family history among patients with urinary bladder cancer.膀胱癌患者家族史的预后价值。
Int J Cancer. 2015 Mar 1;136(5):1117-24. doi: 10.1002/ijc.29062. Epub 2014 Jul 9.
4
A systems biology approach to defining metastatic biomarkers and signaling pathways.一种用于定义转移生物标志物和信号通路的系统生物学方法。
Wiley Interdiscip Rev Syst Biol Med. 2009 Jul-Aug;1(1):89-96. doi: 10.1002/wsbm.6.
5
Polymorphisms in MMP9 and SIPA1 are associated with increased risk of nodal metastases in early-stage cervical cancer.基质金属蛋白酶9(MMP9)和信号转导和激活因子1(SIPA1)的多态性与早期宫颈癌淋巴结转移风险增加相关。
Gynecol Oncol. 2010 Mar;116(3):539-43. doi: 10.1016/j.ygyno.2009.09.037. Epub 2009 Nov 10.
6
Distinct inherited metastasis susceptibility exists for different breast cancer subtypes: a prognosis study.不同乳腺癌亚型存在明显的遗传易感性转移:一项预后研究。
Breast Cancer Res. 2009;11(5):R75. doi: 10.1186/bcr2412.
7
Survival in non-Hodgkin's lymphoma by histology and family history.非霍奇金淋巴瘤按组织学类型和家族史的生存率。
J Cancer Res Clin Oncol. 2009 Dec;135(12):1711-6. doi: 10.1007/s00432-009-0618-0. Epub 2009 Jun 17.

本文引用的文献

1
The updated Swedish family-cancer database used to assess familial risks of prostate cancer during rapidly increasing incidence.更新后的瑞典家庭癌症数据库用于评估在发病率迅速上升期间前列腺癌的家族风险。
Hered Cancer Clin Pract. 2006 Dec 15;4(4):186-92. doi: 10.1186/1897-4287-4-4-186.
2
Epidemiology of urinary bladder cancer: from tumor development to patient's death.膀胱癌流行病学:从肿瘤发生到患者死亡
World J Urol. 2007 Jun;25(3):285-95. doi: 10.1007/s00345-007-0168-5.
3
Genetic determinants of cancer metastasis.癌症转移的遗传决定因素。
Nat Rev Genet. 2007 May;8(5):341-52. doi: 10.1038/nrg2101.
4
Integrative molecular concept modeling of prostate cancer progression.前列腺癌进展的整合分子概念模型
Nat Genet. 2007 Jan;39(1):41-51. doi: 10.1038/ng1935. Epub 2006 Dec 17.
5
Clinical cancer advances 2006: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.2006年临床癌症进展:癌症治疗、预防及筛查方面的重大研究进展——美国临床肿瘤学会报告
J Clin Oncol. 2007 Jan 1;25(1):146-62. doi: 10.1200/JCO.2006.09.7030. Epub 2006 Dec 8.
6
The epidemiology of renal cell carcinoma.肾细胞癌的流行病学
J Urol. 2006 Dec;176(6 Pt 1):2353-8. doi: 10.1016/j.juro.2006.07.130.
7
Mechanisms of disease: The epidemiology of bladder cancer.疾病机制:膀胱癌的流行病学
Nat Clin Pract Urol. 2006 Jun;3(6):327-40. doi: 10.1038/ncpuro0510.
8
The role of tumor metastasis suppressors in cancers of breast and prostate.肿瘤转移抑制因子在乳腺癌和前列腺癌中的作用。
Front Biosci. 2006 Sep 1;11:2845-60. doi: 10.2741/2013.
9
Screening for bladder tumours in men aged 60-70 years with a bladder tumour marker (UBC) and dipstick-detected haematuria using both white-light and fluorescence cystoscopy.使用膀胱肿瘤标志物(UBC)以及通过试纸检测血尿,同时运用白光和荧光膀胱镜,对60至70岁男性进行膀胱肿瘤筛查。
Scand J Urol Nephrol. 2006;40(1):26-30. doi: 10.1080/00365590500368807.
10
Prognostic markers for bladder cancer: International Consensus Panel on bladder tumor markers.膀胱癌的预后标志物:膀胱癌肿瘤标志物国际共识小组
Urology. 2005 Dec;66(6 Suppl 1):64-74. doi: 10.1016/j.urology.2005.08.065.

膀胱癌和肾细胞癌的生存率具有家族性。

Survival in bladder and renal cell cancers is familial.

作者信息

Ji Jianguang, Försti Asta, Sundquist Jan, Lenner Per, Hemminki Kari

机构信息

Center for Family and Community Medicine, Karolinska Institute, Alfred Nobels alle 12, 14183 Huddinge, Sweden.

出版信息

J Am Soc Nephrol. 2008 May;19(5):985-91. doi: 10.1681/ASN.2007070818. Epub 2008 Feb 6.

DOI:10.1681/ASN.2007070818
PMID:18256358
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2386727/
Abstract

Having family members with cancer has been associated with increased risk for bladder and renal cell cancers, but its association with survival has not been examined. This study was an analysis of the nationwide Swedish Family-Cancer Database and revealed that survival for bladder and renal cell cancers was similar whether the cancer was familial or sporadic; however, when survival in offspring was analyzed according to the affected parents' length of survival, prognosis was concordant. Cox proportional hazard regression models revealed that for bladder cancer, the risk for death among offspring whose parents survived > or =5 yr was approximately one third that of offspring whose parents survived <5 yr, after adjustment for gender, age at diagnosis, time period of diagnosis, socioeconomic status, and geographic region (adjusted hazard ratio 0.34; 95% confidence interval 0.15 to 0.80, for overall mortality). A risk of similar magnitude was found for renal cell cancer (adjusted hazard ratio 0.38; 95% confidence interval 0.16 to 0.87, for overall mortality). These population-level findings suggest heritability of prognosis for bladder and renal cell cancers. Genetic factors likely contribute to the mechanism underlying this observation.

摘要

家庭成员患癌症与膀胱癌和肾细胞癌风险增加相关,但尚未研究其与生存率的关系。本研究对瑞典全国性家庭癌症数据库进行了分析,结果显示,无论是家族性还是散发性的膀胱癌和肾细胞癌,其生存率相似;然而,根据受影响父母的生存时长分析后代的生存率时,预后是一致的。Cox比例风险回归模型显示,对于膀胱癌,在调整性别、诊断时年龄、诊断时间段、社会经济地位和地理区域后,父母存活≥5年的后代死亡风险约为父母存活<5年的后代的三分之一(总体死亡率调整后风险比0.34;95%置信区间0.15至0.80)。肾细胞癌也发现了类似程度的风险(总体死亡率调整后风险比0.38;95%置信区间0.16至0.87)。这些人群水平的研究结果提示膀胱癌和肾细胞癌预后具有遗传性。遗传因素可能促成了这一观察结果背后的机制。